Press

 

Media presence is a key part of making society aware of developments in biotechnology and its benefits.This is where we post all our press releases. If you are a journalist interested in learning more about the biotechnology sector, contact Ángel Luis Jiménez, our Communication Director: ajimenez@asebio.com 

Search engine
Sesión celebrada en BIOSPAIN 2025 para presentar el mapa de AseBio sobre la geopolítica de la biotecnología
From Vertical Sector to Critical Technology: Biotechnology at the Epicenter of the New Global Geopolitical Map
BioSpain
  • AseBio presents at BIOSPAIN 2025 the report “The new geopolitics of biotechnology”, which analyzes the global race of the sector and Spain’s strategic role in the new balance of power among the United States, Europe, and China.
  • The United States leads biotechnology, but its hegemony is being challenged by China’s rapid rise in patents and research. Europe, positioned between the two, remains relevant but must narrow its innovation gap to remain competitive.
  • The Spanish model has shown strength in R&D, but it must transform into commercial success, job creation, and economic leadership.
AseBio
Científico analizando muestras en un laboratorio
Personalized Vaccines, CAR-T, and AI: The New Horizon of Cancer Research
Healthcare · Innovative drugs · Personalized medicine · Advanced therapies
  • Cancer research is advancing thanks to biotechnology, but it still faces challenges such as equitable access and the need for stable funding.
  • On World Cancer Research Day, the AECC Scientific Foundation reminds us that only through the joint commitment of patients, healthcare professionals, and the research community will it be possible to achieve more significant breakthroughs and improve quality of life.
  • Sofía Cabezudo, Head of Innovation, highlights the role of biotechnology in driving innovative therapies, enhancing treatment personalization, and placing the patient at the center of cancer research.
AseBio
Científica de VIVA in Vitro trabajando en sus laboratorios
Sepsis causes up to 20,000 annual deaths in Spain: Biotechnology is revolutionizing early diagnosis
Healthcare · Personalized medicine
  • At a global scale, according to WHO data, between 48 and 50 million cases are estimated each year, with at least 11 million deaths.
  • Early detection and biotechnological innovation — ultrafast diagnosis, personalized medicine, and comprehensive support — are key to saving lives and reducing long-term effects.
  • Viva In Vitro, an AseBio member, has developed VIVA-ELISA, a biotechnology tool that rapidly detects activation of the NLRP3 inflammasome, enabling evaluation of the immune system’s ability to respond even before clinical symptoms appear.
     
AseBio
Agricultor trabajando en el campo
Biotechnology and Regenerative Agriculture: The alliance for the future of farming
Climate change · Agrifood · Food & feed · Agriculture
  • Regenerative Agriculture aims to restore agricultural ecosystems through healthier soils, resilient crops, and systems that capture carbon, generate income, and address the challenges of climate change.
  • Bayer promotes regenerative agriculture through practices that improve soil health, more resilient hybrid and oilseed crops, and biotechnology with NGT, complemented by digitalization, circular economy initiatives, and collaboration with farmers to enhance productivity and sustainability.
AseBio
BIOSPAIN 2023 celebrado en a Fira de Barcelona
BIOSPAIN becomes an annual event, consolidating its leadership as a driving force of the Spanish biotechnology sector
BioSpain
  • BIOSPAIN 2025 will take place from October 7 to 9 in Barcelona, under the motto 'Global crossroads, local vibes', with the aim of connecting local talent with European and American ecosystems.
  • The eleventh edition in 2023 achieved record participation figures, bringing together more than 2,200 attendees from nearly 1,000 companies across 34 countries, and generating over 5,000 one-to-one meetings. Expectations are that this edition will reach an equal or greater impact.
  • The host city for BIOSPAIN 2026 will be announced during the official events at BIOSPAIN 2025, while Barcelona is confirmed as the venue for the 2027 and 2029 editions.
     
AseBio
Banderas de la Unión Euroepa, sede de la CE
The european bioeconomy urges the EC to harmonize policies, strengthen funding, and create more favorable markets for innovation
Bioeconomy · Circular economy
  • The European project ShapingBio, of which AseBio is a partner, has presented a report with key recommendations for the upcoming EU Bioeconomy Strategy, aimed at driving a more sustainable, circular, and competitive economy.
  • The recommendations are based on broad engagement with nearly 2,000 key bioeconomy stakeholders, including policymakers, industry leaders, researchers, and civil society representatives.
  • These recommendations have been well received by the European Commission and could strengthen Europe’s resilience, competitiveness, and sustainability within the framework of its new Bioeconomy Strategy.
AseBio
Agricultor en un campo de cultivo
86 AseBio members working on new solutions to tackle the challenges of the Green Transition
Climate change · Agrifood · Food & feed · Agriculture · Bioeconomy · Circular economy
  • The report prepared by AseBio as an initiative of its Sustainability Committee identifies 587 solutions focused on identifying and adopting new ways of production and consumption that respect the planet’s balance.
  • 33% of these solutions target areas such as animal health and nutrition, food safety, functional foods, fermentation or biocatalysis, and substance detection.
  • Biotechnology in the green transition continues to face barriers at many levels. According to the findings, several factors currently hinder the shift toward a more sustainable system.
AseBio
laboratorio
Next-generation CAR-T therapies for pediatric sarcomas: Biotechnological advances show promising results
Healthcare
  • The World Health Organization recognizes over 150 different types of sarcomas, a rare disease that poses significant diagnostic and therapeutic challenges.
  • The CIBER Cancer Area (CIBERONC) is developing advanced cellular therapies targeting pediatric sarcomas, with a special focus on Ewing sarcoma.
  • Collaboration among clinical centers, academic groups, and biotech companies is essential to accelerate research and overcome the challenges posed by rare diseases
AseBio
Comisión Europea
AseBio presents its proposals to the European Commission for the future Biotech Act
Healthcare · Agrifood · Industrial biotechnology
  • We warmly welcome this initiative, convinced that a solid legislative framework is essential to unlocking the full potential of biotechnology for the benefit of the economy, society, and Europe’s strategic autonomy.
  • Our contribution addresses the sector’s main challenges with proposals focused on three pillars: agile funding for innovation, simpler and faster regulation, and a more cohesive and globally competitive EU.
  • These proposals are aligned with the consensus of the European industry and reflect our strong commitment to building a resilient and world-leading biotechnology ecosystem.
AseBio